Gene therapy for deafness.
Gene therapy for deafness.
复制标题
DOI:
10.1038/gt.2013.39
复制
发表时间:
2013-12
期刊:
影响因子:
5.1
通讯作者:
Raphael, Y.
中科院分区:
文献类型:
--
作者:
Kohrman, D. C.;Raphael, Y.
Hearing loss is the most common sensory deficit in humans and can result from genetic, environmental, or combined etiologies that prevent normal function of the cochlea, the peripheral sensory organ. Recent advances in understanding the genetic pathways that are critical for the development and maintenance of cochlear function, as well as the molecular mechanisms that underlie cell trauma and death have provided exciting opportunities for modulating these pathways to correct genetic mutations, to enhance endogenous protective pathways for hearing preservation and to regenerate lost sensory cells with the possibility of ameliorating hearing loss. A number of recent animal studies have used gene-based therapies in innovative ways toward realizing these goals. With further refinement, some of the protective and regenerative approaches reviewed here may become clinically applicable.
登录
查看更多内容
DOI:
10.1007/bf00186783
发表时间:
1995-02-01
期刊:
ANATOMY AND EMBRYOLOGY
影响因子:
--
作者:
KIKUCHI, T;KIMURA, RS;ADAMS, JC
通讯作者:
ADAMS, JC
影响因子:
2.8
作者:
FORGE, A
通讯作者:
FORGE, A
影响因子:
3.7
作者:
Lalwani, AK;Mhatre, AN
通讯作者:
Mhatre, AN
影响因子:
3.4
作者:
Ge, Xianxi;Jackson, Ronald L.;Balough, Ben J.
通讯作者:
Balough, Ben J.
DOI:
10.1097/mao.0b013e318277a40e
发表时间:
2013-01
期刊:
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
影响因子:
--
作者:
Du X;Chen K;Kuriyavar S;Kopke RD;Grady BP;Bourne DH;Li W;Dormer KJ
通讯作者:
Dormer KJ